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Abstract
Adult mesenchymal stem cells with multilineage differ-
entiation potentially exist in the bone marrow, but have
also been isolated from the peripheral blood. The differ-
entiation of stem cells after leaving their niches depends
predominately on the local milieu and its new microenvi-
ronment, and is facilitated by soluble factors but also by
the close cell-cell interaction in a three-dimensional tis-
sue or organ system. We have isolated CD34-negative,
mesenchymal stem cell lines from human bone marrow
and peripheral blood and generated monoclonal cell
populations after immortalization with the SV40 large T-
antigen. The cultivation of those adult stem cell clones in
an especially designed in vitro environment, including
self-constructed glass capillaries with defined growth
conditions, leads to the spontaneous establishment of
pleomorphic three-dimensional cell aggregates (spher-
oids) from the monoclonal cell population, which consist
of cells with an osteoblast phenotype and areas of miner-
alization along with well-vascularized tissue areas. Modi-
fications of the culture conditions favored areas of bone-
like calcifications. After the transplantation of the at least
partly mineralized human spheroids into different mu-
rine soft tissue sites but also a dorsal skinfold chamber,
no further bone formation could be observed, but angio-
genesis and neovessel formation prevailed instead, en-
abling the transplanted cells and cell aggregates to sur-
vive. This study provides evidence that even monoclonal
adult human CD34-negative stem cells from the bone
marrow as well as peripheral blood can potentially differ-
entiate into different mesenchymal tissues depending on
the local milieu and responding to the needs within the
microenvironment.
Copyright © 2005 S. Karger AG, Basel
Abbreviations used in this paper
BMP bone morphogenetic protein 
MMP matrix metalloproteinase
PlGF placental growth factor 
VEGF vascular endothelial growth factor
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Introduction
The plasticity or transdifferentiation potential of adult
stem cells and their implications for regenerative medicine
in the future is still subject to controversy among scientist
and clinicians. Adult hematopoietic stem cells can be iso-
lated from the bone marrow, peripheral blood and umbili-
cal cord blood for immediate and successful clinical use.
An increasing number of reports have suggested that adult
stem cells have a considerable degree of pluripotency and
plasticity, which apparently allows their differentiation
into a variety of tissue-specific progenitors in vivo and
their application in organ regeneration after injury or dis-
ease [Horwitz et al., 1999; Pittenger et al., 1999]. We have
cloned various adult stem cell lines from the bone marrow
and the peripheral blood in different species. All stem cell
lines consisted of two populations after cultivation in vitro:
a fibroblast-like and predominately quiescent (non-active)
population and a potentially active subpopulation, which
can eventually differentiate into hematopoietic, endothe-
lial and mesenchymal precursor cells. One observation was
that CD34-negative, fibroblast-like cells from the canine
bone marrow can give rise to CD34-positive hematopoiet-
ic precursor cells [Huss et al., 1995; Huss, 1998]. With a
cloned adult murine cell line from peripheral blood mono-
nuclear cells, we achieved complete and long-term hemato-
poietic recovery in syngeneic mice after myeloablative
therapy [Lange et al., 1999]. Similarly, a monoclonal cell
line from canine peripheral blood was also used for an
autologous transplantation resulting in cells co-expressing
mesenchymal markers in vitro and in vivo, e.g. osteocalcin
[Huss et al., 2000]. The monoclonal human cell line also
showed mesenchymal differentiation and expressed type I
and type V collagen along with osteocalcin in vitro, sugges-
tive of its osteogenic potential [Thalmeier et al., 1996].
Human monoclonal cell lines are also composed of a
small Rho123low, CD34-positive subpopulation and a
Rho123high, CD34-negative major population [Conrad et
al., 2002]. The hematopoietic transcription factors GATA-
1, -2 and -3 were only expressed in the Rholow population,
while the Rhohigh population expressed vascular endothe-
lial growth factor (VEGF) and Tie-1 [Ziegler et al., 1999],
which has already been demonstrated on primitive stem
cells. Tie-1 is also present on endothelial cells and hemato-
poietic progenitors, which draws attention to the heman-
gioblast as a potential pluripotent stem cell, with plasticity
being between hematopoietic and mesenchymal lineages
[Baron, 2001], especially because all cells co-expressed
bone morphogenetic protein (BMP) receptor 1A. Based on
previous observations and the molecular phenotype of
available human adult cell lines [Thalmeier et al., 2001;
Conrad et al. 2002], we investigated the possibility wheth-
er potentially multipotent and monoclonal adult stem
cells can respond adequately to inductive in vitro condi-
tions when grown in three-dimensional spheroids, as
demonstrated for embryonic stem cells [Zhang et al.,
2001]. The consecutive use of an appropriate in vivo
model for an extended differentiation of those preformed
aggregates could give further insight into the biology and
plasticity of adult stem cells, which might participate in
tissue regeneration and organ maintenance.
Materials and Methods
Cell Lines
We used the CD34-negative fibroblast-like cell lines L88/5 iso-
lated from bone marrow cells [Thalmeier et al., 1996] and the periph-
eral blood-derived human CD34-negative CD105-positive cell line
V54/2 [Conrad et al., 2002]. All different cell lines were cloned after
immortalization with the SV40 large T-antigen. The random inser-
tion of usually 9–11 copies did not change the biological behavior of
any cell line as observed over the past 4 years [unpubl. observation].
Three-Dimensional Aggregate Cultures
Tissue aggregates were obtained here using glass capillaries,
which enables close cell-cell interaction of adult stem cells during
development and differentiation. Cells were cultivated for about 4–6
weeks in glass capillaries (0.5–1.0 mm in diameter and 30–50 mm
long), placed in tissue culture flasks (Corning Costar, Cambridge,
Mass., USA), grown in RPMI (Gibco Life Technologies, Eggenstein,
Germany) supplemented with 10% fetal calf serum, 4 mmol/l L-
glutamine and penicillin (60 mg/l)/streptomycin (100 mg/l). Cells
were incubated at 37 °C in a humidified incubator with 5% CO2.
Medium was changed 2–3 times per week. Within a 30-day period,
three-dimensional aggregates grew out of the capillaries. These aggre-
gates were transferred to a 96-well plate and cultivated for further
10–14 days. During this cultivation interval, the aggregates attached
to the plastic surface and fibroblast-like cells grew out as a cell layer.
Because of ample medium consumption, cell bodies were transferred
to 24-well plates and 6 wells, respectively. At this time, a Ca2PO4-
supplemented mineral solution (250 mM; Druefusan; Syxyl, Co-
logne, Germany) as well as BMP4 (10 ng/ml; R&D, Wiesbaden, Ger-
many) were added to the culture media. Afterwards, cell aggregates
were cultured as described above.
Immunhistostaining of Paraffin-Embedded Sections
Explanted and in vitro generated tissue aggregates were fixed
overnight in 4% PBS buffered formalin and embedded in paraffin. 2-
to 5-Ìm sections were stained with different commercially available
and human specific antibodies. Using biotinylated detection sys-
tems, sections were treated with 0.3% hydrogen peroxide to block
endogenous peroxidase activity. Deparaffinized slides were incu-
bated with either CD31 (dilution: 1:30; Dako, Hamburg, Germany),
osteocalcin (dilution: 1:400; Biotrend, Cologne, Germany), CD34
(dilution: 1:50; BD-Pharmingen, Heidelberg, Germany) or CD117
and VEGF (dilution: 1:100; Dako, Hamburg, Germany). CD31 and
osteocalcin were detected by an AP-conjugated detection system
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(Dako). The signal was finally developed using Fast Red (Sigma, Dei-
senhofen, Germany) as substrate. CD34, VEGF and CD117 were
sequentially incubated with a biotinylated detection system (Dako).
Visualization was achieved with 3-amino-9-ethylcarbazol substrate
(Sigma).
In situ Hybridization
Deparaffinzed 6- to 8-Ìm sections were pretreated with a Target
Retrieval Solution (Dako) at 97 °C in a water bath for 15 min. Subse-
quent sections were pretreated with 0.2% protease E (Sigma) at 37°C
for 2 min and fixed in 4% paraformaldehyde for 10 min. Endogenous
peroxidase activity was blocked using triethanolamine/acetic acid an-
hydride (Sigma). Sections were dehydrated and briefly denaturated at
96°C for 2 min and incubated overnight at 37°C with the C17 probe.
The biotinylated probe was detected using the ABC-Elite Kit (Vector,
Burlingame, Calif., USA) and visualized with Nova Red (Vector).
Reverse Transcription-Polymerase Chain Reaction
For first-strand synthesis 1–2 Ìg RNA from L88/5 and V54/2
cells were dissolved in 9.7 Ìl volume together with 2 Ìl random hex-
amers (100 ÌM stock, Amersham Pharmacia Biotech) and incubated
at 65 °C for 20 min, before the samples were centrifuged for 10 s and
placed on ice. In a second step, 5! first-strand buffer (Gibco kit cata-
logue No. 28025-013) was mixed with 2 Ìl 0.1 M 1,4-dithio-DL-
threitol (Sigma), 1 Ìl M-MLV reverse transcription, 0.8 Ìl 25 mM
dNTPs (Amersham Pharmacia Biotech) and 0.5 Ìl RNasin (Prome-
ga). This mixture was added to the solution from step 1 and incu-
bated together at 37°C for 90 min, then at 70°C for 10 min and
finally stored at –20°C. The PCR reaction was performed in tubes
with a 0.2-ml-thin wall with 2.5 Ìl of 10! buffer II, 1.5 Ìl MgCl2,
0.5 Ìl dNTPs (10 ÌM stock), 0.2 Ìl Amplitaq gold and 1 Ìl first-
strand cDNA or water (negative control) or RNA (no reverse trans-
cription control) in 18.3 Ìl water. 1 Ìl of each forward and reverse
primer from the designed transcription product was added from a
25-ÌM stock solution. The PCR program ran for 35 cycles with an
annealing temperature of 58 °C for 30 s and an amplification temper-
ature of 70°C also for 30 s. The samples were then run on a 2%
agarose gel. Primer sequences are available from the authors. The
osteocalcin primers were 5)-CCG GGC CGT AGA AGC GCC GAT
A-3) and 5)-ATG GCC CTC ACA CTC CTC G-3) (297 bp) and for
osteopontin 5)-CAT TGA CTC GAA CGA CTC TG-3) and 5)-ATT
CTA TGG TTG GGG AAG GGT-3) (354 bp).
Electron Microscopy
For scanning electron microscopy, adult stem cells were grown in
chamber slides on circular coverslips and fixed in Karnovsky/Kar-
novsky 2 as described and published elsewhere [Huss, 1997]. For
transmission electron microscopy, tissue aggregates were fixed in
0.5% glutaraldehyde overnight and processed as described.
Transplantation into Dorsal Skinfold Chambers as a Host Site
Male CD-1 nude mice (25–30 g; Charles River, Sulzfeld, Germa-
ny) were used for the experiments, which have been approved by the
Bavarian Ethics Committee on Animal Rights and Protection. Sur-
gery necessary for the implantation of chambers and the transplanta-
tion of stem cells aggregates was done under aseptic conditions with
the animals under general anesthesia (i.m. ketamine 125 mg/kg body
weight, i.m. xylazine 15 mg/kg body weight).
Dorsal skinfold chambers were fitted to the animals as described
previously [Lehr et al., 1993]. A skinfold along the spine was ex-
tended and sandwiched between two symmetrical titanium frames.
A circular area (Ø 15 mm) of one layer of the skinfold was completely
resected, and the exposed inside of the opposing layer with a striated
skin muscle on top was covered by a removable coverslip hold by one
frame. Following a 48-hour recovery period, the coverslip was
removed, one aggregate of stem cells was placed on the striated mus-
cle tissue, and the chamber was closed again. From then on, animals
were housed in an incubator (34–37°C, air humidity 80%; Dräger
8000 NC, Lübeck, Germany) with free access to tap water and stan-
dard chow food.
Graft size and the process of vascularization were investigated
daily by intravital microscopy (Zeiss Axiotech, Oberkochen, Germa-
ny). Awake animals were immobilized in plastic tube restrainers, and
the skinfold preparations were attached to the microscopic stage. Pic-
tures obtained by transillumination (395–440 nm) were recorded
with a CCD-video camera (Pieper FK 6990 IQ-S, Schwerte, Germa-
ny) and videotaped. Samples of the striated skin muscle bearing the
transplant were taken at various time points after the first appear-
ance of graft vascularization.
Transplantation into Murine Soft Tissue as a Host Site
The skin at the back was incised along the right scapular line.
Stem cell aggregates were transplanted into the subcutaneous soft tis-
sue; thereafter the incision was closed by suture. For the following 6
days, animals were housed in an incubator with free access to stan-
dard chow food and tap water. On day 7, the incision was reopened,
the subcutaneous area was explored, and aggregates were harvested.
Results
Adult Human Stem Cell Clones
More than 2 decades ago, a highly disputed discussion
started whether there is a common CD34-negative pre-
cursor cell for CD34-positive hematopoietic stem cells
and CD34-negative (mesenchymal) stromal elements
[Singer et al., 1984], which initiated the discussion of the
plasticity of adult stem cells. Therefore, we decided to
generate adult stem cell clones from different sources in
different species [Huss, 2000] to address the issue of plas-
ticity within a clonal cell population. We used cell lines
from human bone marrow [Thalmeier et al., 1996] and
peripheral blood [Conrad et al., 2002] to perform our
experiments. The human stem cell lines predominantly
grow adherent as fibroblast-like cells, while few non-
adherent CD34-positive cells are only loosely attached to
the underlying fibroblast-like cells, which spontaneously
emerge from the underlying CD34-negative progenitors
as published previously [Conrad et al., 2002] (fig. 1).
Osteogenesis and Small Diameter Vessel Formation
in Three-Dimensional Spheroids
As published previously, the development of three-
dimensional tissue aggregates is advantageous or even a
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Fig. 1. Morphology of the CD34-negative adult progenitor cell clone
L88/5. a Most of the cells of the monoclonal CD34-negative stem cell
from the L88/5 cell line grow adherent as fibroblast-like and spindle-
shaped cells, while fewer cells in culture are non-adherent, CD34-
positive cells, spontaneously emerging from the underlying CD34-
negative progenitors [Conrad et al., 2002]. Those CD34-positive cells
can also return to a more quiescent state as CD34-negative fibro-
blast-like, adherent cells. b Scanning electron microscopy of the
bone-marrow-derived CD34-negative cell line L88/5. The non-
adherent CD34-positive cell is loosely attached to the underlying
spindle-shaped CD34-negative cell by some fibers of the extracellular
matrix. 
Fig. 2. Spontaneous differentiation of a monoclonal bone-marrow-
derived progenitor cell line in a glass capillary. a 10–20 cells of each
stem cell clone were implanted into a 0.5-mm-large glass capillary.
b The cells continue to grow and fill up the intracapillary space with-
in 2–3 weeks. c After 4 weeks, three-dimensional spheroids grow out
of both open ends of the glass capillary. d These three-dimensional
spheroids also consist of a fibroblast-like cell type after continuous
growth in a cell culture dish.
necessary precondition to establish the formation of hu-
man bone from adult stem cells [Kale et al., 2000].
Although small cell clusters or spheroids can develop
spontaneously on a confluent stem cell layer in vitro, we
constructed our own glass capillaries for the generation of
tissue aggregates. As shown in figure 2a, 10–20 cells from
a CD34-negative adult cell line were placed into such a
glass capillary, where they grew continuously (fig. 2b)
until the development of three-dimensional spheroids at
the tip end after 3–4 weeks (fig. 2c). Morphologically
identical fibroblast-like cells emerged from the up to
10-mm-large tissue aggregates when placed into a tissue
culture dish similar to the growth conditions of the prima-
ry cells (fig. 2d). Although, the in vitro generated three-
dimensional tissue aggregates consisted of the pre-seeded
CD34-negative stem cells, serial sections of the formalin-
fixed and paraffin-imbedded spheroids (fig. 3a) revealed a
distinct organization of the tissue aggregates, with distin-
guishable areas of osteogenesis and neoangiogenesis
(fig. 3b). The aggregate showed an internal positive stain-
ing with antibodies against osteocalcin (fig. 3c), while cells
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Fig. 3. Immunohistostaining and transmission electron microsco-
py of paraffin-embedded three-dimensional spheroids. a Complete
three-dimensional spheroid derived from the clonal progenitor cell
line and grown in a defined milieu after placement into a tissue cul-
ture dish. b Spheroids were fixed in buffered formalin and embedded
in paraffin before preparing serial sections. Conventional HE stain-
ing already shows two distinct areas: a central area of the aggregate
with cells that contain more cytoplasm with smaller nuclei (upper
right) and a ribbon-like structure with more cuboidal-shaped cells
with larger nuclei on the outside of the aggregate (lower left). c The
inner ‘nucleus’ stains positive with antibodies against osteocalcin
and MMP-9 (not shown), suggesting the osteogenic potential of these
more cuboidal cells in this area. d Instead, the outer ‘ribbon’ of the
aggregate contains predominantly VEGF-positive spindle-shaped
cells, which is the typical feature of CD34-negative stem cells
undergoing endothelial differentiation [Huss et al., 2004]. e Among
the VEGF-positive angioblasts, there are already some mature endo-
thelial cells expressing PECAM-1 (CD31). f Electron microscopy
shows the formation of small capillary-like structures, while other
cells present condensed chromatin. 
of the outer area revealed expression of the angiogenic
marker VEGF (fig. 3d) and matrix metalloproteinase
(MMP)-9 (not shown). Neoangiogenesis was confirmed
by the expression of CD31 (PECAM-1) on rare endothe-
lial cells (fig. 3e) and the formation of small-diameter
neovessels (fig. 3f), which is characteristic of CD34-nega-
tive stem cells undergoing spontaneous differentiation
[Huss et al., 2004]. The organization of the in vitro gener-
ated three-dimensional spheroids with areas of minerali-
zation and endothelial differentiation occurred sponta-
neously at the given conditions, but the addition of
Ca2PO4-rich medium supplemented with BMP4 shifted
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Fig. 4. Mineralization of three-dimen-
sional spheroids after applying osteo-
genic cell culture conditions. a Stem
cell aggregates after additional incuba-
tion in a Ca2PO4-supplemented miner-
al solution and BMP4 showing a dif-
ferent gross appearance after 2 weeks
in culture. b, c von Kossa staining
showing dark areas of mineralization.
Osteocalcin (d) and osteopontin (e)
mRNA in L88/5 and V54/2 cell
clones.
L88/5   V54/2 L88/5  V54/2
100 µm
the differentiation entirely towards areas of mineraliza-
tion (fig. 4a–c) and the expression of human specific
mRNA for osteocalcin and osteopontin (fig. 4d, e).
Milieu-Dependent Differentiation in vivo
The spontaneous development of heterogeneous mes-
enchymal tissue aggregates from a single adult stem cell
clone in vitro suggested the transfer of the three-dimen-
sional spheroids into an in vivo model to investigate fur-
ther maturation of the preformed and predifferentiated
tissue. The subcutaneous implantation into the soft tissue
close to the back muscle of a nude recipient mouse did not
induce any differentiation of the transplanted cells into
mature tissue (fig. 5a). Instead, a heterogeneous distribu-
tion of CD31-positive endothelial cells along with osteo-
calcin-positive bone precursors, c-kit-positive hemato-
poietic progenitors and CD34-positive angiogenic cells
was detected (fig. 5b–e) without evidence of organ forma-
tion. In situ hybridization with a human centromer-spe-
cific probe revealed the coexistence of murine and human
tissue, particularly at the site of the transplanted tissue
and murine site of implantation (fig. 5f). The sole trans-
plantation of the in vitro generated tissue into a random
site of a nude mouse was not sufficient to induce matura-
tion or committed differentiation.
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Fig. 5. Histology and in situ hybridization of subcutaneous soft tis-
sue implants. a HE staining of the implanted human cellular aggre-
gate between the host (murine) muscle and adipose tissue 7 days after
transplantation. b Enlargement still shows few CD34-positive cells in
the grafted aggregate. c, d Osteocalcin-positive cells, which co-
express c-kit (CD117) indicating activation. e As shown prior to
implantation, the majority of CD31-positive endothelial cells are
located circular around the transplanted cell aggregate to anastomose
with host-derived vessels. f In situ hybridization with the human cen-
tromer-specific C17 probe reveals the presence of implanted human
cells.
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Fig. 6. Analysis of three-dimensional spheroids after implantation
into dorsal skinfold chambers. a Aggregate from a bone-marrow-
derived progenitor cell line (approximately 1 mm in diameter) 24 h
after implantation into the dorsal skinfold chamber of nude mice.
Pictures were obtained by blue-light transillumination, which is
absorbed by hemoglobin; blood-filled vessels appear dark against the
bright background. No angiogenesis was observed at this time. b The
same aggregate 4 days after implantation shows numerous newly
formed microvessels sprouting from host vessels and directed to the
graft. c Grafts viewed with a higher magnification reveal signs of
angiogenesis. The microvasculature is characterized by a heteroge-
neous angio-architecture with premature vessels: capillary sprouts
(a), irregular branching patterns (b), irregular vessel calibers (c) and
bleeding (d). d On day 7, the graft is reduced, disclosing the subjacent
host muscle; newly formed vessels show signs of maturation: sup-
plying arteriole (a), draining venule (b) and preexisting host capillar-
ies in the striated skin muscle (c). e Longitudinal section of an
explanted aggregate side after 7 days in a dorsal skinfold chamber
and staining for PECAM-1-positive endothelial cells, which are seen
between the implant (top) and the host musculature. f Human cen-
tromere-specific in situ hybridization (C17) to detect implanted
human cells from the aggregate in the murine dorsal skinfold cham-
ber.
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We transplanted the clonal tissue aggregates into dor-
sal skin chambers of nude mice. During the 7-day study,
the implanted tissue showed no angiogenesis on day 1
(fig. 6a), but neovessel formation with capillary sprouting
and branching occurred between days 4 and 7 (fig. 6b–d).
On day 7, the aggregates have largely disappeared, but a
mature vessel network remained connected to arterioles
and postcapillary venules that apparently originated from
capillaries of the underlying striated skin muscle. Time
course and morphology of neovessel formation and matu-
ration in our model resembles results found after implan-
tation of syngeneic pancreatic islet cells. In the same mod-
el, a xenogeneic reaction was accompanied by rejection
and maintenance of both the graft as well as its supplying
microvasculature at the same time [Menger et al., 1990],
whereas in our study the vessel network was maintained.
There was also no significant inflammatory infiltrate.
Like the in vivo adaptation after transplantation of the
tissue aggregates to the soft tissue site of the recipient
nude mice, angiogenesis occurred particularly at the inter-
face between murine host tissue und implanted human
cells (fig. 6e, f).
Discussion
The degree of plasticity of adult stem cells is still a mat-
ter of controversy. However, there is undisputed evidence
that adult stem cells can differentiate into various tissues,
including the differentiation into endothelial cells during
neoangiogenesis [Grant et al., 2002; Otani et al., 2002].
Although most of the multipotent stem cells are routinely
isolated from the bone marrow [Pittenger et al., 1999],
there is also evidence of circulating CD34-negative,
CD45-negative and CD105-positive stem cells in the
peripheral blood [Huss et al., 2000]. Differentiation of
stem cells can be induced and directed by various in vitro
measures, like the application of appropriate growth fac-
tors and cytokines or the co-cultivation of stem cells on
tissue-inductive scaffolds [Mackay et al., 1998; Bianchi et
al., 2001; Li et al., 2001]. Previous experiments on bone
formation and vascularized tissues from mesenchymal
stem cells were performed with a number of cultured cells
consisting of a heterogeneous cell population without evi-
dence of clonality [Dennis et al., 2002; Harris and Coop-
er, 2004]. We used instead a three-dimensional structure
approach to generate bone or bone precursors in vitro
[Kale et al., 2000] from human monoclonal human stem
cell lines similar to primary cells, as also described by oth-
ers [Shi et al., 2002]. However, not only can areas of min-
eralization be observed in three-dimensional spheroids,
blood vessels are also formed and mature in the close
interaction of different cell types [Korff et al., 2001],
depending on the milieu and local environment [Kaushal
et al., 2001]. The implantation of cells and tissues into the
dorsal skinfold chamber of T-cell-deficient nude mice
(Crl:CD1-nu; Charles River) enables real-time observa-
tion of neoangiogenesis and vessel formation together
with cell motility in vivo [Lehr et al., 1993]. Previously,
the dorsal skinfold chamber was also found to be a suit-
able model to study cell aggregates such as ovarian folli-
cles [Vollmar et al., 2001] and pancreatic islet cells [Men-
ger et al., 1990]. Although we succeeded in the generation
of osteocalcin-positive areas and the establishment of
mineralized tissue in our aggregates, no exclusive and
mature bone maturation was seen in vitro or in vivo. Nev-
ertheless, the co-expression of osteocalcin and MMP-9 is
in accordance with a possible osteoblastic nature of those
differentiated stem cells, because osteoblasts also use this
proteinase (gelatinase A) for migration and tissue inva-
sion [Festuccia et al., 1999]. Instead of further maturation
into bone tissue in vivo, angiogenesis prevailed in both
mouse models (implantation of the cell aggregates into the
soft tissue and into the dorsal skin chamber) suggesting
that the local on-site milieu was in favor of angiogenesis
and failed to support or maintain osteogenesis. Apparent-
ly, most of the neovascularization stemmed from the host
site and formed anastomoses between the murine host
and the human graft. Adult stem cells may also induce or
facilitate differentiation of preexisting progenitor cells or
a subpopulation of precursor cells, e.g. by releasing stimu-
lating and activating cytokines and growth factors, which
in turn participate in creating an inflammatory environ-
ment which is necessary for the enhancement of arterio-
genesis [Harraz et al., 2001; Hartlapp et al., 2001]. Such a
growth factor is placental growth factor (PlGF), which is
able to recruit preexisting and primed stem cells from oth-
er sources or niches like the bone marrow [Hattori et al.,
2002] and is able to directly stimulate the formation of
arteriogenesis [Pipp et al., 2003]. Bone-marrow-derived
stem cells also provide functional hemangioblast activity
in vivo [Grant et al., 2002] or modulate the angiogenesis
at the lesion site [Otani et al., 2002]. Adult bone marrow
cells also contain a subset of CD34-positive Flk-1/
KDR(+) hemangioblasts [Pelosi et al., 2002], and the
impaired recruitment of bone-marrow-derived stem cells
interferes with successful angiogenesis [Lyden et al.,
2001]. Endothelial progenitors, which still share the
CD34 and the flk-1 antigen with hematopoietic precursor
cells, have also been isolated from the peripheral blood
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[Asahara et al., 1997] and show enhanced vascular devel-
opment in the appropriate model, e.g. ischemic tissue
[Masuda et al., 2000]. While SCL is a definitive marker
for hemangioblasts in zebrafish [Gehring et al., 1998],
CD133 has been identified as a marker of peripheral
blood cells with either hematopoietic or endothelial po-
tential [Loges et al., 2004].
After trauma, injury or ischemia, neoangiogenesis is
the stereotypical response of almost any regenerative tis-
sue. Soluble factors involved in the initiation of angiogen-
esis and proliferation of endothelial cells are angiopoietin
and VEGF [Huang et al., 1999] as well as PlGF, which is
also able to revascularize ischemic tissues [Lutton et al.,
2002], also by the recruitment of VEGF-receptor-1
(VEGFR1)-positive stem cells from the bone marrow
[Hattori et al., 2002]. We also showed that VEGF-positive
cells become an integral part of tissue aggregates in vitro,
most likely to ensure the survival of stem cells in subopti-
mal growing conditions, but also to form an angiogenic
gradient within the three-dimensional spheroid to attract
more stem cells to the area of vasculature and to improve
the microcirculatory system in the graft [Harraz et al.,
2001; Hartlapp et al. 2001; Huss et al., 2004].
In conclusion, our model has given novel insight into
the physiology and plasticity of adult stem cells and mes-
enchymal tissue derived from monoclonal adult stem cell
lines.
References
Asahara, T., T. Murohara, A. Sullivan, M. Silver,
R. van der Zee, T. Li, B. Witzenbichler, G.
Schatteman, J.M. Isner (1997) Isolation of pu-
tative progenitor endothelial cells for angiogen-
esis. Science 275: 964–967.
Baron, M.H. (2001) Molecular regulation of em-
bryonic hematopoiesis and vascular develop-
ment: a novel pathway. J Hematother Stem
Cell Res 10: 587–594.
Bianchi, G., A. Muraglia, A. Daga, G. Corte, R.
Cancedda, R. Quarto (2001) Microenviron-
ment and stem cell properties of bone marrow-
derived mesenchymal stem cells. Wound Re-
pair Regen 9: 460–466. 
Conrad, C., B. Göttgens, S. Kinston, J. Ellwart, R.
Huss (2002) GATA transcription in a small
rhodamine 123(low)CD34(+) subpopulation of
a peripheral blood-derived CD34(–)CD105(+)
mesenchymal cell line. Exp Hematol 30: 887–
895.
Dennis, J.E., J.P. Carbillet, A.I. Caplan, P. Char-
bord (2002) The STRO-1+ marrow cell popula-
tion is multipotential. Cells Tissue Organs 170:
73–82. 
Festuccia, C., D. Giunciuglio, F. Guerra, I. Villa-
nova, A. Angelucci, P. Manduca, A. Teti, A.
Albini, M. Bologna (1999) Osteoblasts modu-
late secretion of urokinase-type plasminogen
activator (uPA) and matrixmetalloproteinase-9
(MMP-9) in human prostate cancer cells pro-
moting migration and matrigel invasion. Oncol
Res 11: 17–31.
Gehring, M., A.R.F. Rodaway, G. Göttgens, R.K.
Patient, A.R. Green (1998) The SCL gene spe-
cifies haemangioblast development from early
mesoderm. EMBO J 17: 4029–4045.
Grant, M.B., W.S. May, S. Caballero, G.A.J.
Brown, S.M. Guthrie, R.N. Mames, B.J. Byrne,
T. Vaught, P.E. Spoerri, A.B. Peck, E.W. Scott
(2002) Adult hematopoietic stem cells provide
functional hemangioblast activity during reti-
nal neovascularization. Nat Med 8: 607–612.
Harraz, M., C. Jiao, H.D. Hanlon, R.S. Hartley,
G.C. Schatteman (2001) CD34-blood-derived
human endothelial cell progenitors. Stem Cells
19: 304–312. 
Harris CT, L.F. Cooper (2004) Comparison of bone
graft matrices for human mesenchymal stem
cell-directed osteogenesis. J Biomed Mater Res
68: 747–755.
Hartlapp, I., R. Abe, R.W. Saeed, T. Peng, W.
Voelter, R. Bucala, C.N. Metz (2001) Fibro-
cytes induce an angiogenic phenotype in cul-
tured endothelial cells and promote angiogene-
sis in vivo. FASEB J 15: 2215–2224.
Hattori, K., B. Heissig, Y. Wu, S. Dias, R. Tejada,
B. Ferris, D.J. Hicklin, Z. Zhu, P. Bohlen, L.
Witte, J. Hendrikx, N.R. Hackett, R.G. Crys-
tal, M. Moore, Z. Werb, D. Lyden, S. Rafii
(2002) Placental growth factor reconstitutes he-
matopoiesis by recruiting VEGFR1+ stem cells
from bone-marrow microenvironment. Nat
Med 8: 841–849.
Horwitz, E.M., D.J. Prockop, L.A. Fitzpatrick,
W.W.K Koo, P.L. Gordon, M. Neel, M. Suss-
man, P. Orchard, J.C. Marx, R.E. Pyeritz, M.
Brenner (1999) Transplantability and thera-
peutic effects of bone marrow-derived mesen-
chymal cells in children with osteogenesis im-
perfecta. Nat Med 5: 111–116.
Huang, X.L., N. Takakura, T. Suda (1999) In vitro
effects of angiopoietins and VEGF on hemato-
poietic and endothelial cells. Biochem Biophys
Res Commun 264: 133–138.
Huss, R., D.S. Hong, P.A. McSweeney, C.A. Hoy,
H.J. Deeg (1995) Differentiation of canine
marrow cells with hematopoietic characteris-
tics from an adherent stromal cell precursor.
Proc Natl Acad Sci USA 92: 748–752.
Huss, R. (1997) Functional and ultrastructural
studies on the burst of c-kit ligand containing
secretory vesicles. Acta Histochem 99: 111–
116.
Huss, R. (1998) CD34-negative stem cells as the
earliest precursors of hematopoietic progeny.
Exp Hematol 26: 1022–1023.
Huss R. (2000) Isolation of primary and immortal-
ized CD34– hematopoietic and mesenchymal
stem cells from various sources. Stem Cells 18:
1–9.
Huss, R., C. Lange, E.M. Weissinger, H.J. Kolb, K.
Thalmeier (2000) Evidence of peripheral
blood-derived, plastic adherent CD34–/low he-
matopoietic stem cell clones with mesenchymal
stem cell characteristics. Stem Cells 18: 252–
260.
Huss, R., M. Heil, S. Moosmann, T. Ziegelhöffer,
S. Sagebiel, S. Seliger, S. Kinston, B. Göttgens
(2004) Improved arteriogenesis with simulta-
neous skeletal muscle repair in ischemic tissue
by SCL+ multipotent adult progenitor cell
(MAP-C) clones from peripheral blood. J Vasc
Res 41: 422–431.
Kale, S., S. Biermann, C. Edwards, C. Tarnowski,
M. Morris, M.W. Long (2000) Three-dimen-
sional cellular development is essential for ex
vivo formation of human bone. Nat Biotechnol
18: 929–930.
Kaushal, S., G.E. Amiel, K. Guleserian, O.M. Sha-
pira, T. Perry, F.W. Sutherland, E. Rabkin,
A.M. Moran, F.J. Schoen, A. Atala, S. Soker, J.
Bischoff, J.E. Mayer (2001) Functional small-
diameter neovessels created using endothelial
progenitor cells expanded ex vivo. Nat Med 7:
1035–1040.
Korff, T., S. Kimmina, G. Martiny-Baron, H.G.
Augustin (2001) Blood vessel maturation in a
3-dimensional spheroidal coculture model: di-
rect contact with smooth muscle cells regulates
endothelial cell quiescence and abrogates
VEGF responsiveness. FASEB J 15: 447–457.
Lange, C., C. Kaltz, K. Thalmeier, H.J. Kolb, R.
Huss (1999) Long-term hematopoietic recon-
stitution of syngeneic mice with a peripheral
blood-derived, monoclonal CD34–, Sca-1+,
Thy-1 low, c-kit+ stem cell line. J. Hematother
Stem Cell Res 8: 335–342.
Mesenchymal Tissues from CD34-Negative
Adult Progenitor Cell Clones
Cells Tissues Organs 2005;179:91–101 101
Lehr, H.A., M. Leunig, M.D. Menger, D. Nolte, K.
Messmer (1993) Dorsal skinfold chamber tech-
nique for intravital microscopy in nude mice.
Am J Pathol 143: 1055–1062.
Li, Y., T. Ma, D.A. Kniss, S.T. Yang, L.C. Lasky
(2001) Human cord cell hematopoiesis in
three-dimensional nonwoven fibrous matrices:
in vitro stimulation of the marrow microenvi-
ronment. J Hematother Stem Cell Res 10: 355–
368.
Loges, S., B. Fehse, M.A. Brockmann, K. Lamszus,
M. Butzal, M. Guckenbiehl, G. Schuch, S. Er-
gün, U. Fischer, A.R. Zander, D.K Hossfeld,
W. Fiedler, U.M. Gehling (2004) Identification
of the adult human hemangioblast. Stem Cells
Dev 13: 229–242.
Lutton, A., M. Tjwa, L. Moons, Y. Wu (2002)
Revascularization of ischemic tissues by PlGF
treatment, and inhibition of tumor angiogene-
sis, arthritis and atherosclerosis by anti-Flt1.
Nat Med 8: 831–840.
Lyden, D., K. Hattori, S. Dias, C. Coast, P. Blaikie,
L. Butros, A. Chadburn, B. Heissig, W. Marks,
L. Witte, Y. Wu, D.J. Hicklin, Z. Zhu, N.R.
Hackett, R.G. Crystal, M.A.S. Moore, K.A.
Hajjar, K. Manova, R. Benezra, S. Rafii (2001)
Impaired recruitment of bone-marrow-derived
endothelial and hematopoietic precursor cells
blocks tumor angiogenesis and growth. Nat
Med 7: 1194–1201.
Mackay, A.M., S.C. Beck, J.M. Murphy, F.P. Bar-
ry, C.O. Chichester, M.F. Pittenger (1998)
Chondrogenic differentiation of cultured hu-
man mesenchymal stem cells from marrow.
Tissue Eng 4: 415–428.
Masuda, H., C. Kalka, T. Asahara T (2000) Endo-
thelial progenitor cells for regeneration. Hum
Cell 13: 153–160.
Menger, M.D., S. Jaeger, P. Walter, F. Hammersen,
K. Messmer (1990) A novel technique for stud-
ies on the microvasculature of transplanted
islets of Langerhans in vivo. Int J Microcirc
Clin Exp 9: 103–117.
Otani, A., K. Kinder, K. Ealt, F.J. Otero, P. Schim-
mel, M. Friedlander (2002) Bone marrow-de-
rived stem cells target retinal astrocytes and
can promote or inhibit retinal angiogenesis.
Nat Med 8: 1004–1010.
Pelosi, E., Valtieri M., S. Coppola, R. Botta, M.
Gabbianelli, V. Lulli, G. Marziali, B. Masella,
R. Muller, C. Sgadari, U. Testa, G. Bonanno,
C. Peschle (2002) Identification of the heman-
gioblast in postnatal life. Blood 100: 3203–
3208.
Pipp, F., M. Heil, K. Issbrücker, T. Ziegelhoeffer,
S. Martin, J. van den Heuvel, H.H. Weich, B.
Fernandez, G. Golomb, P. Carmeliet, W.
Schaper, M. Clauss (2003) VEGFR-1-selective
VEGF homologue PIGF is arteriogenic: Evi-
dence for a monocytemediated mechanism.
Circ Res 92: 378–385.
Pittenger, M.F., A.M. Mackay, S.C. Beck, R.K.
Jaiswal, R. Douglas, J.D. Mosca, M.A. Moor-
man, D.W. Simonetti, S. Craig, D. Marshak
(1999) Multilineage potential of adult human
mesenchymal stem cells. Science 276: 318–
321.
Singer, J.W., A. Keating, J. Cuttner, A.M. Gowan,
R. Jacobson, P.D. Killen, J.W. Moohr, V. Naj-
feld, J. Powell, J. Sanders (1984) Evidence for a
stem cell common to hematopoiesis and its in
vitro microenvironment: studies of patients
with clonal hematopoietic neoplasia. Leuk Res
8: 535–545.
Shi, S., S. Gronthos, S. Chen, A. Reddi, C.M. Coun-
ter, P.G. Robey, C.Y. Wang (2002) Bone for-
mation by human postnatal bone marrow stro-
mal stem cells is enhanced by telomerase. Nat
Biotechnol 20: 587–591.
Thalmeier, K., P. Meissner, G. Reisbach, L. Hült-
ner, B.T. Mortenson, A. Brechtel, R.A. Oosten-
dorp, P. Dörmer (1996) Constitutive and mod-
ulated cytokine expression in two permanent
human bone marrow stromal cell lines. Exp
Hematol 24: 1–9.
Thalmeier, K., P. Meissner, S. Moosmann, S. Sage-
biel, I. Wiest, R. Huss (2001) Mesenchymal dif-
ferentiation and organ distribution of estab-
lished human stromal cell lines in NOD/SCID
mice. Acta Haematol 105: 150–165.
Vollmar, B., M.W. Laschke, R. Rohan, J. Koenig,
M.D. Menger (2001) In vivo imaging of physio-
logical angiogenesis from immature to preovu-
latory ovarian follicles. Am J Pathol 159:
1661–1670.
Zhang, S.C., M. Wernig, I.D. Duncan, O. Brüstle,
J.A. Thomson (2001) In vitro differentiation of
transplantable neural precursors from human
embryonic stem cells. Nat Biotechnol 19:
1129–1133.
Ziegler, B.L., M. Valtieri, G.A. Porada, R. De Mar-
ia, R. Muller, B. Masella, M. Gabbianelli, I.
Casella, E. Pelosi, T. Bock, E.D. Zanjani, C.
Peschle (1999) KDR receptor: a key marker
defining hematopoietic stem cells. Science 28:
1553–1558.
